Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$12.3M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 8 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -6%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 8 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $16.8M is below the $22.5M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2026-06-30 (10-Q). The cash figure is from 2025-12-31, so the two are not the same balance-sheet date — the schedule has not been refiled since.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~8.5% on $4.63B of debt.
Cash of $16.8M fully covers short-term debt of $14.7M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 1 positive fiscal year (FY2023). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $24.00 today, the market must believe free cash flow compounds 28.9%/yr for a decade (off $62.9M on the 3-yr avg basis).
On the basis ($44.9M) the requirement is 33.8%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
Default is 10.9% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.02B shares (market data) · net debt $4.61B
mean -27.6% · volatility σ 58% · implied rate exceeded in 1/6 yrs
Central path = implied 28.9%/yr growth; shaded band = ±1σ (58%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 18 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDT | $1.4B | 51.3× | 30.7× | 2.9× | 31.2% | 43.8% | 5.9% | 13.8% | 13.8% | 0.0× | 51 |
| NUTX | $1.4B | 19.1× | 4.1× | 1.6× | 82.4% | 50.8% | 8.1% | 21.5% | 19.0% | -0.5× | 22 |
| RSKD | $1.1B | — | — | 3.3× | 5.2% | 51.7% | -8.0% | -9.4% | -9.4% | — | 9 |
| AHG | $1.1B | 126.0× | — | 78.0× | -6.4% | -0.1% | -135% | -10.3% | -10.3% | — | — |
| QNST | $996M | 12.4× | 24.2× | 0.8× | 18.3% | 11.3% | 6.3% | 25.1% | 20.7% | -1.5× | 41 |
| MAX | $873M | 37.8× | 43.8× | 0.8× | 28.8% | 15.0% | 2.3% | 616% | 16.3% | 4.8× | 22 |
| PAYS | $787M | 107.2× | 49.3× | 9.6× | 40.5% | 59.4% | 9.2% | 15.6% | 13.4% | -0.8× | 23 |
| PHR | $772M | 311.0× | 28.5× | 1.6× | 14.5% | — | 0.5% | 0.7% | 0.7% | -2.5× | 31 |
| CASS | $674M | 20.2× | — | 3.5× | 5.3% | — | 18.4% | 14.5% | 14.5% | — | 41 |
| PRTH | $647M | 11.5× | 7.9× | 0.7× | 8.3% | — | 5.8% | -55.5% | 5.9% | 4.7× | 20 |
| RMNI | $463M | 12.7× | 6.4× | 1.1× | -1.7% | 60.4% | 8.8% | -137% | 92.4% | -0.8× | 16 |
| CTEV | $407M | — | 38.5× | 0.4× | 3.7% | — | -29.4% | 163% | -6.4% | — | 13 |
| FVRR | $302M | 15.0× | 13.1× | 0.7× | 10.1% | 81.6% | 4.9% | 5.1% | 5.1% | -9.3× | 23 |
| PSFE | $293M | — | 7.6× | 0.2× | -0.2% | 56.4% | -10.7% | -27.9% | -5.6% | 6.8× | — |
| IMXI | $277M | 8.5× | 4.2× | 0.5× | -7.7% | — | 5.4% | 20.3% | 9.2% | 0.4× | 22 |
| CNDT | $240M | — | — | 0.1× | -9.4% | 18.1% | -5.6% | -24.8% | -12.4% | — | 29 |
| ALIT | $236M | — | — | 0.1× | -3.0% | 33.8% | -137% | -297% | -102% | — | — |
| DHX | $196M | — | 77.8× | 1.5× | -9.9% | 84.7% | -10.6% | -14.3% | -10.9% | 9.4× | 7 |
| OPRX | $176M | 34.5× | 15.1× | 1.6× | 18.8% | 67.3% | 4.7% | 4.0% | 3.3% | 0.2× | 11 |
Peers = companies sharing CTEV's sector (Services-Business Services, NEC) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 16 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $965.4M 100.0% | $930.6M 100.0% | $961.5M 100.0% | $1.08B 100.0% | $1.12B 100.0% | $937.8M 100.0% | $982.9M 100.0% | $1.04B 100.0% |
| Selling, General & Admin | $221.5M 22.9% | $150.9M 16.2% | $143.2M 14.9% | $166.8M 15.5% | $151.1M 13.5% | $355.6M 37.9% | $75.2M 7.7% | $77.6M 7.5% |
| Total Operating Expenses | $936.6M 97.0% | $2.32B 249.4% | $799.5M 83.2% | $1.44B 133.6% | $731.5M 65.5% | $1.07B 114.1% | $614.7M 62.5% | $613.3M 58.9% |
| Operating Income | $28.8M 3.0% | -$1.39B -149.4% | $162.0M 16.8% | -$362.7M -33.6% | $386.1M 34.5% | -$131.8M -14.1% | $368.2M 37.5% | $427.5M 41.1% |
| Interest Expense | $392.0M 40.6% | $326.4M 35.1% | $333.2M 34.7% | $303.4M 28.1% | $267.5M 23.9% | $335.6M 35.8% | $376.3M 38.3% | $383.3M 36.8% |
| Interest & Investment Income | $1.6M 0.2% | $3.1M 0.3% | $8.2M 0.9% | $3.5M 0.3% | $30K 0.0% | $288K 0.0% | $196K 0.0% | $51K 0.0% |
| Pretax Income | -$373.1M -38.6% | -$1.77B -190.3% | -$107.1M -11.1% | -$560.7M -51.9% | $135.5M 12.1% | $135.5M 14.4% | -$546.9M -55.6% | $10.5M 1.0% |
| Income Tax Expense | -$88.8M -9.2% | -$124.9M -13.4% | -$15.4M -1.6% | $12.2M 1.1% | $33.4M 3.0% | $33.4M 3.6% | -$26.3M -2.7% | $800K 0.1% |
| Net Income | -$284.3M -29.4% | -$1.65B -176.9% | -$91.7M -9.5% | -$572.9M -53.1% | $102.1M 9.1% | -$520.6M -55.5% | $9.7M 1.0% | $36.2M 3.5% |
| Per Share | ||||||||
| EPS (Basic) | -$17.30 | -$101.92 | -$5.69 | -$0.90 | $0.16 | -$1.11 | $0.02 | — |
| EPS (Diluted) | -$17.30 | -$101.92 | -$5.69 | -$0.90 | $0.16 | -$1.11 | $0.02 | — |
| Weighted Avg Shares (Basic) | 16.4M | 16.1M | 16.1M | 638.9M | 651.0M | 470.8M | 415.7M | — |
| Weighted Avg Shares (Diluted) | 16.4M | 16.1M | 16.1M | 638.9M | 651.5M | 470.8M | 415.7M | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 6-yr range · 25th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 6-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 163% against ROIC -6% — 170% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| SG&A | 7.5 | 7.7 | 37.9 | 13.5 | 15.5 | 14.9 | 16.2 | 22.9 |
| Operating Income | 41.1 | 37.5 | -14.1 | 34.5 | -33.6 | 16.8 | -149.4 | 3.0 |
| Income Tax | 0.1 | -2.7 | 3.6 | 3.0 | 1.1 | -1.6 | -13.4 | -9.2 |
| Net Income | 3.5 | 1.0 | -55.5 | 9.1 | -53.1 | -9.5 | -176.9 | -29.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CTEV: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -10.43pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 3.7% | 10.9% (today's — no rate published for this year) | -7.2pts |
| FY2020 | -1.4% | 10.9% (today's — no rate published for this year) | -12.3pts |
| FY2021 | 4.0% | 7.9% | -3.8pts |
| FY2022 | -4.3% | 9.5% | -13.8pts |
| FY2023 | 1.9% | 9.6% | -7.6pts |
| FY2024 | -22.4% | 10.4% | -32.8pts |
| FY2025 | 0.5% | 10.1% | -9.7pts |
| Now | -6.4% | 10.9% | -17.3pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2018 | not reported | 41.1% | 3.5% |
| FY2019 | not reported | 37.5% | 1.0% |
| FY2020 | not reported | -14.1% | -55.5% |
| FY2021 | not reported | 34.5% | 9.1% |
| FY2022 | not reported | -33.6% | -53.1% |
| FY2023 | not reported | 16.8% | -9.5% |
| FY2024 | not reported | -149.4% | -176.9% |
| FY2025 | not reported | 3.0% | -29.4% |
$2.4B of goodwill — 54% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer. With goodwill over half the base, the ex-goodwill figure divides by a small remainder and moves sharply — read it as a direction, not a precise rate.
ROIC ex-goodwill is 1.05% against 0.49% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Fewer than three profitable years with a cash flow statement, so cash conversion cannot be judged.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Missing from our data, so excluded from this answer: 3 years of cash flow.
Stressed coverage falls to 0.1x — below the level at which interest is reliably covered.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 0.07x |
| 5% | 0.07x |
| 10% | 0.07x |
| 15% | 0.06x |
| 20% | 0.06x |
| 25% | 0.06x |
| 30% | 0.05x |
| 35% | 0.05x |
| 40% | 0.04x |
| 45% | 0.04x |
| 50% | 0.04x |
| 55% | 0.03x |
| 60% | 0.03x |
Ladder as of 2026-06-30 (10-Q); cash from the 2025-12-31 balance sheet; FCF from FY2025. Free cash flow is negative, so projected resources fall rather than accumulate.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Free cash flow is negative, so debt service depends on the cash balance rather than on the business.
At $24.00, free cash flow must compound 28.98%/yr for 10 years. It has no positive compounding record to compare against.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 40.7% | 29.0% |
| FY2021 | 4.4% | 29.0% |
| FY2022 | −11.7% | 29.0% |
| FY2023 | −77.8% | 29.0% |
| FY2024 | −116.7% | 29.0% |
The implied rate has been matched or beaten in 1 of the last 5 years.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-26 | 8 co-filers Group filing | Open-market buyindirect | 20,834 | $24.07 | $501k |
| 2026-10-26 | 16 co-filers Group filing | Open-market buyindirect | 20,834 | $24.07 | $501k |
| 2026-10-23 | 8 co-filers Group filing | Open-market buyindirect | 50,000 | $23.53 | $1.2m |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 2026-10-23 | 16 co-filers Group filing | Open-market buyindirect | 50,000 | $23.53 | $1.2m |
| 2026-10-15 | Main Jennifer Elizabeth Director | Grant | 3,113 | $0.00 | $0 |
| 2026-10-15 | 2 co-filers SVP, Chief Growth Officer | 10b5-1 plan sale | 5,812 | $23.81 | $138k |
| 2026-10-14 | 2 co-filers SVP, Chief Growth Officer | Tax withholding | 9,994 | $23.94 | $239k |
| 2026-09-21 | 2 co-filers EVP&CFO | 10b5-1 plan sale | 7,877 | $30.50 | $240k |
| 2026-09-21 | 2 co-filers EVP&CFO | 10b5-1 plan sale | 1,148 | $31.19 | $36k |
| 2026-09-14 | Letham Thomas Benjamin Director | Grant | 2,880 | $0.00 | $0 |
| 2026-08-28 | 2 co-filers Pres., CEO & Executive Chair | Open-market buyindirect | 1,950 | $38.48 | $75k |
| 2026-08-27 | 2 co-filers Pres., CEO & Executive Chair | Open-market buyindirect | 4,500 | $38.81 | $175k |
| 2026-08-14 | Misencik Tiffani SVP, Chief Growth Officer | Open-market sale | 8,850 | $40.07 | $355k |
| 2026-08-10 | Mintz William B. SVP, Chief Strategy Officer | Open-market sale | 8,431 | $34.24 | $289k |
| 2026-08-05 | Mintz William B. SVP, Chief Strategy Officer | Tax withholding | 3,622 | $26.13 | $95k |
| 2026-08-05 | Garis Douglas Michael EVP&CFO | Tax withholding | 11,711 | $26.13 | $306k |
| 2026-06-30 | Albinson Brock SVP, Chief Accounting Officer | Grant | 3,649 | $0.00 | $0 |
| 2026-06-09 | Carol Nutter SVP, Chief People Officer | Open-market buy | 875 | $28.41 | $25k |
| 2026-05-19 | Prince John Michael Director | Open-market buy | 10,000 | $16.00 | $160k |
| 2026-05-18 | Kim Michael EVP, Chief Digital Officer | Open-market buy | 3,000 | $16.65 | $50k |
| 2026-05-18 | 2 co-filers Pres., CEO & Executive Chair | Open-market buyindirect | 9,720 | $12.92 | $126k |
| 2026-05-18 | 2 co-filers Pres., CEO & Executive Chair | Open-market buyindirect | 11,200 | $11.88 | $133k |
| 2026-04-29 | Kap Jason Lamar Director | Grant | 8,977 | $0.00 | $0 |
| 2026-04-29 | Prince John Michael Director | Grant | 8,977 | $0.00 | $0 |
| 2026-04-29 | Klapstein Julie D Director | Grant | 8,977 | $0.00 | $0 |
| 2026-04-29 | Klein Michael Stuart Director | Grant | 8,977 | $0.00 | $0 |
| 2026-04-29 | Clarke Richard A Director | Grant | 8,977 | $0.00 | $0 |
| 2026-04-29 | Colaluca Anthony Jr Director | Grant | 8,977 | $0.00 | $0 |
| 2026-04-29 | Harris C Martin Director | Grant | 8,977 | $0.00 | $0 |
| 2026-03-31 | Albinson Brock SVP, Chief Accounting Officer | Grant | 2,956 | $0.00 | $0 |
| 2026-03-16 | Garis Douglas Michael EVP&CFO | Open-market buy | 1,300 | $17.69 | $23k |
| 2026-03-12 | Kim Michael EVP, Chief Digital Officer | Open-market buy | 15,000 | $16.50 | $248k |
| 2026-03-02 | O'Neil Tara SVP, General Counsel | Open-market buy | 750 | $12.99 | $10k |
| 2026-03-01 | 3 co-filers SVP, Chief Growth Officer | Tax withholding | 1,660 | $13.47 | $22k |
| 2026-03-01 | 4 co-filers EVP, Chief Operating Officer | Tax withholding | 1,906 | $13.47 | $26k |
| 2026-03-01 | Albinson Brock SVP, Chief Accounting Officer | Grant | 23,243 | $0.00 | $0 |
| 2026-03-01 | 6 co-filers SVP, General Counsel | Tax withholding | 89 | $13.47 | $1k |
| 2026-03-01 | 3 co-filers EVP&CFO | Tax withholding | 5,331 | $13.47 | $72k |
| 2026-03-01 | 2 co-filers Group filing | Tax withholding | 1,616 | $13.47 | $22k |
| 2026-03-01 | 6 co-filers EVP, Chief Digital Officer | Tax withholding | 189 | $13.47 | $3k |